Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/11/07/2976860/0/en/Adagene-Presents-Two-Posters-with-New-Insights-on-Increased-Therapeutic-Index-for-Masked-Anti-CTLA-4-SAFEbody-ADG126-Muzastotug-and-Data-Reinforcing-Clinical-Safety-and-Efficacy-fo.html

GLOBENEWSWIRE
07 Nov 2024

https://www.globenewswire.com//news-release/2024/01/16/2810362/0/en/Adagene-Presents-Interim-Results-Reinforcing-Best-in-Class-Profile-of-Masked-anti-CTLA-4-SAFEbody-ADG126-muzastotug-in-Combination-with-Pembrolizumab-in-Metastatic-Microsatellite-s.html

GLOBENEWSWIRE
16 Jan 2024

https://www.globenewswire.com//news-release/2024/01/04/2803770/0/en/Adagene-To-Present-Interim-Results-of-Masked-anti-CTLA-4-SAFEbody-ADG126-muzastotug-in-Combination-with-Pembrolizumab-in-MSS-CRC-at-ASCO-GI-Symposium.html

GLOBENEWSWIRE
04 Jan 2024